26
Participants
Start Date
September 15, 2020
Primary Completion Date
March 30, 2022
Study Completion Date
March 30, 2022
CYT107
IM administration at 10μg/kg twice a week for three weeks and up to 7 administrations according to Hospital length of stay
Placebo
IM administration at 10μg/kg twice a week for three weeks and up to 7 administrations according to Hospital length of stay
Stony Brook Medicine, Stony Brook
University of Florida College of Medicine, Gainesville
Cleveland Clinic Lerner College of Medicine, Cleveland
Missouri Baptist Medical Center, St Louis
Rutgers Health, New Brunswick
Collaborators (1)
Washington University School of Medicine
OTHER
Amarex Clinical Research
OTHER
Revimmune
INDUSTRY